e-learning
resources
London 2016
Tuesday, 06.09.2016
Asthma points to ponder
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Codeine for treatment of cough variant asthma
A. Fuat Kalyoncu (Ankara, Turkey), Tuba Erdogan, Ozge Ozturk Aktas, Ebru Çelebioglu, Gül Karakaya, A. Fuat Kalyoncu
Source:
International Congress 2016 – Asthma points to ponder
Session:
Asthma points to ponder
Session type:
Poster Discussion
Number:
3369
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Fuat Kalyoncu (Ankara, Turkey), Tuba Erdogan, Ozge Ozturk Aktas, Ebru Çelebioglu, Gül Karakaya, A. Fuat Kalyoncu. Codeine for treatment of cough variant asthma. Eur Respir J 2016; 48: Suppl. 60, 3369
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Effect of cromolyn inhaler on resistant neutrophilic cough variant of asthma, A phase two clinical trial
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014
Chronic cough and asthma-like symptoms – Not always asthma
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
The effect of treatment duration by inhaled glucocorticosteroids, on “cough variant asthma” in children
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013
Efficacy of carbamazepine in treatment of bronchial asthma
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Predictors of good inhaler technique in asthma and COPD
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Monitoring of airway resistance (Raw) in exacerbation of asthma
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Atomization inhalation on the NO content in the airway of patients with bronchial asthma
Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases
Year: 2016
Characterisation of asthma patients with persistent airflow obstruction
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Comparable effectiveness of budesonide/formoterol combination and fluticasone for the treatment of cough variant asthma
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013
Bronchodilators in school children with asthma and normal FEV1
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Long-acting anticholinergics in the treatment of severe asthma with irreversible airway obstruction
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD)
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Asthma control, symptoms and exacerbations across treatment levels in patients with asthma
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013
Do correct steps using pMDI technique with spacer predict no exacerbations of Asthma or COPD?
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016
Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Monitoring of cough trends in COPD
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
FeNO-guided management of asthma during pregnancy reduces respiratory symptoms and asthma diagnosis in childhood
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016
Importance of inhalation device in asthma and COPD: A consensus using Delphi
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept